Watch: Rutgers principal investigator on new COVID-19 therapeutic clinical trial

Clinical trial is seeking adults who are COVID-19-positive within one week and who are not in hospital

With so much research focused on a vaccine for the coronavirus, those working to find a short-term treatment may not be as visible to the public eye. But scientists at Rutgers University are leading a clinical trial using a three-drug combination to assess if the medications, when taken together, can shorten the duration of the illness in those 21 or older who have no or mild symptoms.

To get the answer, researchers will need the help of residents who’ve recently tested positive for the disease. Dr. Jeffrey Carson is the principal investigator in the trial; he joins Anchor Briana Vannozzi to explain.